During the past decade, Alea Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alea Research" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

According to Clinical.Site data, the most researched conditions in "Alea Research" are "Depressive Disorder, Major" (5 trials), "Major Depressive Disorder" (2 trials), "Schizophrenia" (2 trials), "Anhedonia" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Alea Research" in a lesser frequency.

Most popular intervention types in "Alea Research" are "Drug" (13 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aticaprant" (2 trials), "Rapastinel" (2 trials), "AGN-241751" (1 trials) and "Abilify MyCite®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alea Research" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Alea Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Alea Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Alea Research, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".